Mutual Funds
Mutual Funds
Fund Profile
Scheme Profile
Daily NAV
Historical NAV
Category Returns
Dividend Details
Fund Ranking
MF Activities
All Holdings
What's In / What's Out
MF Trends
MF Tools
  Home   >   MUTUAL FUND  >  MUTUAL FUNDS  >  CATEGORY RETURNS
CATEGORY RETURNS      
AMC : Category : Scheme :
Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund-Reg(G)
TypeInvestment In% of NAVNo. of sharesValue (Rs cr)
Domestic EquitiesSun Pharmaceutical Industries Ltd.11.902011293620.4222
Domestic EquitiesApollo Hospitals Enterprise Ltd.5.6477126909.6907
Domestic EquitiesDivi's Laboratories Ltd.5.3275140589.1412
Domestic EquitiesMax Healthcare Institute Ltd.5.3013916009.0963
Domestic EquitiesCipla Ltd.5.0784665398.7139
Domestic EquitiesDr. Reddy's Laboratories Ltd.4.9218638388.4451
Domestic EquitiesLupin Ltd.3.9719295656.8153
Domestic EquitiesTorrent Pharmaceuticals Ltd.3.3998139395.8336
Domestic EquitiesFortis Healthcare Ltd.3.1062577475.3298
Domestic EquitiesLaurus Labs Ltd.2.6496412944.5463
Domestic EquitiesGlenmark Pharmaceuticals Ltd.2.5615182654.3951
Domestic EquitiesAurobindo Pharma Ltd.2.4906307564.2735
Domestic EquitiesMankind Pharma Ltd.1.9081145733.2741
Domestic EquitiesAlkem Laboratories Ltd.1.771256283.0391
Domestic EquitiesBiocon Ltd.1.4881709942.5533
Domestic EquitiesIPCA Laboratories Ltd.1.4647164172.5133
Domestic EquitiesZydus Lifesciences Ltd.1.2310236822.1122
Domestic EquitiesJB Chemicals & Pharmaceuticals Ltd.1.2074101392.0718
Domestic EquitiesAster DM Healthcare Ltd.1.1210274371.9235
Domestic EquitiesGland Pharma Ltd.0.890387251.5276
Domestic EquitiesNarayana Hrudayalaya ltd.0.861183641.4776
Domestic EquitiesAjanta Pharma Ltd.0.846651461.4526
Domestic EquitiesGlaxoSmithKline Pharmaceuticals Ltd.0.678749841.1645
Domestic EquitiesGlobal Health Ltd.0.617994891.0602
Domestic EquitiesEmcure Pharmaceuticals Ltd.0.327633460.5622
Total 70.7720 121.4350
Cash & Cash Equivalents and Net AssetsClearing Corporation of India Ltd.0.2737 0.4697
Cash & Cash Equivalents and Net AssetsNet Receivables/(Payables)0.0219 0.0376
Cash & Cash Equivalents and Net AssetsAccrued Interest0.0000 0.0001
Total 0.2957 0.5074
Overseas EquitiesELI LILLY & CO5.696010989.7736
Overseas EquitiesJOHNSON & JOHNSON4.169432687.1541
Overseas EquitiesABBVIE INC2.811623974.8243
Overseas EquitiesNOVARTIS AG2.115725783.6302
Overseas EquitiesMERCK & CO.INC2.039833663.5001
Overseas EquitiesAMGEN INC1.40307302.4074
Overseas EquitiesTHERMO FISHER SCIENTIFIC INC1.34795072.3128
Overseas EquitiesINTUITIVE SURGICAL INC1.22944842.1094
Overseas EquitiesGILEAD SCIENCES INC1.222316832.0973
Overseas EquitiesABBOTT LABORATORIES1.181723452.0277
Overseas EquitiesNovo Nordisk A/S1.030243961.7677
Overseas EquitiesDANAHER CORP0.85628621.4691
Overseas EquitiesSTRYKER CORP0.81864681.4046
Overseas EquitiesVERTEX PHARMACEUTICALS INC0.81603441.4002
Overseas EquitiesMEDTRONIC PLC0.781617391.3411
Overseas EquitiesRegeneron Pharmaceuticals Inc0.56121430.9630
Overseas EquitiesBECTON DICKINSON AND CO0.32013870.5493
Overseas EquitiesAGILENT TECHNOLOGIES INC0.24633840.4226
Overseas EquitiesIQVIA HOLDINGS INC0.19422210.3333
Overseas EquitiesWATERS CORP0.0910530.1561
Total 28.9323 49.6439
 
Back Back TopTop
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Smart ODR Portal | Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA | Publishing of investor charter information | Annexure A – Investor charter of brokers | Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP | Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure | Details of Research Analyst | UPI QR CODE
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.